Abstract
The ability to visualize musculoskeletal structures with high-resolution ultrasound is an asset to understanding the complexity of psoriatic arthritis (PsA). During the 2021 Annual Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) meeting, 3 topics were presented and discussed in the ultrasound workshop: (1) the progress on the Diagnostic Ultrasound Enthesitis Tool (DUET) project; (2) the sonographic evaluation of joints in PsA–GRAPPA joint project; and (3) extrasynovial lesions in PsA. The ultrasound group aims to develop sonographic tools that are feasible and can be used in standard care to diagnose PsA early. The discussions around these topics will shape the group’s work toward developing a composite index to diagnose PsA early.
Introduction
Musculoskeletal (MSK) ultrasound (US) has been increasingly used in the field of psoriatic arthritis (PsA). Numerous studies have been published in the last decade that improve our understanding of the pathogenesis of this disease.1,2 Further, advances in PsA have triggered discussions around the prevention of PsA by treating high-risk populations.3 Thus, earlier diagnosis—even detection in the preclinical phase—becomes an essential target in research, putting MSK US in a critical position. With the aim of carrying the bench to the bedside, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) US group is working on developing feasible US tools that will improve the care of patients with psoriatic disease (PsD) in clinical practice that can be easily adopted by physicians. In this article, we summarize the current agenda of the GRAPPA US group to achieve that goal.
Update on the Diagnostic Ultrasound Enthesitis Tool Project
The Diagnostic Ultrasound Enthesitis Tool (DUET) project is a GRAPPA-supported study aiming to create a new sonographic enthesitis tool to distinguish patients with PsA from non-PsA patients and to assess its validity and reliability. This tool should help with the early diagnosis of PsA by identifying enthesitis, an important PsA domain that is difficult to diagnose in physical examination. The DUET study is a multicenter, international study involving 23 sites led by GRAPPA members with US expertise. The study will recruit 200 patients with PsA and 200 controls (100 patients with psoriasis [PsO] without arthritis and 100 patients with noninflammatory rheumatic conditions). US assessment involves the evaluation of 16 entheseal sites for signs of enthesitis. Central reading by 3 sonographers (LE, GSK, SZA) will be performed to reduce variation in scoring. We aim to identify the optimal combination of entheseal sites and sonographic lesions that distinguish patients with PsA from controls (DUET score). Updates regarding the progress of the study were presented during the meeting.
Training materials, including videos demonstrating scanning of the entheses and atlas with definitions of elementary lesions of enthesitis, were developed and are available as open resources.4 A virtual training workshop for the study investigators was conducted in September 2020. The workshop included 53 participants from 11 countries. The participants reviewed the study procedures and scanning protocols. An interrater reliability exercise was conducted involving the 3 central readers and showed good agreement among the 3 readers for scoring entheseal sites.5 Recruitment of participants to DUET started in March 2021. Thirty-nine participants recruited from 9 active sites were enrolled in the study (as of September 2021). Recruitment of patients for this study continues, with an anticipated interim analysis in July 2022.
Sonographic Evaluation of Joints in PsA — GRAPPA Joint Project
Diagnosing early PsA may help attenuate early morbidity and joint damage.6 Up to 15% of patients with PsO may have undiagnosed PsA,7 and subclinical synovitis may be underestimated in early PsA.8 Strategies to identify early PsA include patient questionnaires, use of clinical risk factors, and genetic factors. Imaging may improve the sensitivity of detection of early PsA. Longitudinal studies in patients with PsO have suggested that the baseline presence of US signs of synovitis and enthesitis predict the future development of PsA.9,10 However, evaluating entheses with advanced imaging may not provide sufficient diagnostic certainty and may underestimate the degree of inflammatory disease burden. Diagnostic tools aid in increasing diagnostic confidence and may also help in making decisions for treatment. Thus, there is a need to include other domains such as synovial structures and the adjacent perientheseal structures.
Difficulties in evaluating joints in PsA include the heterogeneous distribution of synovitis, the presence of erosive and osteoproliferative changes, and confounding with coexisting osteoarthritis.11 Small studies have suggested the frequent prevalence of synovitis at the hand, wrist, knees, and metatarsophalangeal joints.12,13 Formal scoring systems range from examining large joints only to an extensive investigation of multiple joints, which may not be feasible in daily practice.14,15 There is a need to develop a strategy to examine sentinel or most symptomatic joints as well as a candidate set of joints and their perisynovial structures in patients with PsO to diagnose early evolving PsA. Imaging may also detect early signs of damage at these sites, which may provide prognostic information.
Extrasynovial Lesions in PsA
Within the last 5 years, it has been well recognized that rheumatoid arthritis (RA) leads to more intracapsular inflammation, whereas for PsA, the inflammation is not limited to the capsule and tends to affect the adjacent structures. The literature on the extraarticular domains highlights the importance of several structures, as summarized below.
The small enthesis. Most of the literature on enthesitis is based on the large entheses rather than the small entheses.16 That is most likely due to the relative ease of assessment of the large entheses. The clinical assessment of small entheses is challenging due to their anatomical proximity to the small joints, which are frequently involved in PsA. When a small joint is tender or swollen due to synovitis, it can be difficult to understand the contribution of enthesitis within the same digit. Moreover, enthesitis of the digits may be the only underlying pathology in a patient, whereas the physical examination may lead to mislabeling as joint inflammation. In a previous project in which the aim was to understand explicitly the ability of physical examination to differentiate enthesitis/tendon abnormalities from synovitis of the hand, taking high-resolution US as a gold standard, the agreement between the 2 modalities was found to be very poor for all of these lesions, raising the concern of what does it really mean when there is pain in the hands.17
There are multiple small entheses within the hands that are relatively easily explorable with high-resolution US, and pathologies have been demonstrated in PsA (Figure 1 and Figure 2); flexor tendon enthesitis, specifically new bone formation at the insertion, has been shown to differentiate PsA from RA.18 In another study, the extensor tendon enthesitis was found more often in PsA vs PsO.19 Another enthesis that captured significant interest among sonographers was the extensor tendon insertion to the distal phalanx. Zabotti et al demonstrated that extensor tendon central slip enthesitis is seen exclusively in early PsA vs RA.20 Also, nail disease has been shown to be related to the adjacent extensor tendon enthesitis.21 In addition to the increased prevalence of enthesitis, the latter finding is critical for potentially explaining why nail disease is more frequently associated with PsA.
Flexor mechanism. Both flexor tendons and pulleys play an important role in the function of flexing the fingers. Flexor tenosynovitis is a well-recognized abnormality in PsA. Although it can also be seen in RA, Zabotti et al found that the frequency of flexor tenosynovitis was more common in PsA.22 The increased resolution of the US machines allows for the visualization of structures that could not be easily explored before, and therefore provides new insights into our knowledge of the pathogenesis of PsA. The pulleys are an example of that advancement. Despite the small dimensions of the pulleys, the thickening of the A1 and A2 pulleys can be reliably detected, and was found to be more frequent in patients with PsA than those with RA and healthy people.23 In another study, the Doppler signals within the pulleys were increased in the setting of dactylitis.24 Therefore, the ability to look at smaller structures other than the joints allows for the appreciation of the extensiveness of inflammation and provides further data on the role of the functional enthesis in the process and testing of the synovio-entheseal complex theory.
Skin and subcutaneous edema. In the study mentioned earlier by Zabotti et al,20 the group was also able to demonstrate that the peritendinous edema is exclusively seen in PsA (compared to RA), which may potentially contribute to patients’ stiffness and the inability to flex the fingers fully. In addition to the palmar surface, the epidermal and dermal thickening on the dorsum of the hand has also been shown to be increased in PsA compared to PsO.21
The extensor mechanism. Different from the flexor mechanism, the extensor tendon does not have a tendon sheath but is surrounded by a paratenon layer, which can also be inflamed in the setting of PsA. Macía-Villa et al investigated the link between paratenonitis and synovitis vs systemic enthesitis on US and found that it is associated with enthesitis as opposed to synovitis.25
Nail US. This area has been heavily investigated due to clinical nail disease being a predictor of PsA. The high-resolution US can visualize the nail plate as 2 hyperechoic white bands surrounding a well-defined anechoic layer between the trilaminar appearance.26 The abnormalities of the nail can be seen in various ways, including the thickening of the nail plate and the nail bed. In addition, the structural changes within the nail plate can lead to the absence of trilaminar appearance, either due to the thickening of the deeper layer or the lack thereof. Although studies have constantly found more nail lesions in patients with PsA and PsO than in healthy people, and there is a good agreement between the US and the physical exam of the nail, there are also discrepancies between the 2 methods.27,28,29 It is unclear whether sonographic data add information beyond what is found in the physical examination of the nails in PsD. The value of detecting Doppler signals on the nail bed on US is also debatable due to the high vasculature of the nail bed in healthy individuals.30
In summary, the extraarticular domains on sonography have been demonstrated to be important in PsA. However, most of the literature differentiates PsA from RA, with limited data on PsA vs PsO with joint pain (eg, early diagnosis). In addition, there is little information on the reliability of detecting these extraarticular lesions, and the individual contributions of these lesions to diagnosis have not been studied.
Recognizing the importance of extraarticular domains in PsA, the GRAPPA US group is proceeding with the development of a diagnostic tool that will incorporate these considerations in the screening of patients. Our starting point for these extraarticular domains will be the hands, because of (1) all of the data on extraarticular domains being available for the hands in the US of patients with PsA, and (2) the importance of having a feasible tool that can be used by a large group of healthcare professionals.
Conclusion
The GRAPPA US group is expanding its horizons beyond enthesitis in identifying early PsA. Including synovial structures and the accompanying perientheseal structures may improve diagnostic confidence and provide correlation with patient symptoms. An estimate of inflammatory burden and signs of damage may provide prognostic information and inform therapeutic choices. The candidate US instrument will need to include structures based on a data-driven approach, and those that are feasible and applicable across a broad clinical setting. Thus, widening the scope of use of US moves us a step closer to the holy grail of efficiently identifying early PsA.
Footnotes
As part of the supplement series GRAPPA 2021, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards.
The authors declare no conflicts of interest relevant to this article.
This paper does not require institutional review board/animal approval.
- Accepted for publication December 7, 2021.
- Copyright © 2022 by The Journal of Rheumatology